The main goal of preoperative chemotherapy is to reduce the size of the tumor and allow conservative treatment. Neoadjuvant treatment can affect axillary status with a downstaging in one third of the cases. For these patients, the benefit of axillary node dissection is questioned and the sentinel node biopsy (SLNB) seems to be a relevant...
-
June 2016 (v1)Journal articleUploaded on: March 26, 2023
-
December 2020 (v1)Journal article
Abstract Purpose Iodine-125 ( 125 I) seeds can be used as landmarks to locate non-palpable breast lesions instead of implanting metal wires. This relatively new technique requires a nuclear probe usually used for technetium-99m ( 99m Tc) sentinel node detection. This study aimed to compare the performances of different probes and valid the...
Uploaded on: December 4, 2022 -
February 1, 2019 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
June 2017 (v1)Journal article
International audience
Uploaded on: February 28, 2023 -
October 2022 (v1)Journal article
Objective. Interval debulking surgery is recommended after 3–4 cycles (standard IDS) of neoadjuvant chemotherapy (NACT) for epithelial ovarian cancer (EOC) not able to received upfront complete debulking surgery. However, real world practices frequently report performing IDS after ≥5 NAC cycles (delayed IDS). The aim of this work was to...
Uploaded on: June 24, 2023 -
2025 (v1)Journal article
Objective Treatment of high-grade serous ovarian carcinomas relies on surgery and chemotherapy, potentially followed by bevacizumab and/or poly (ADP-ribose) polymerase inhibitors (PARPi). The modeled CA-125 ELIMination rate constant K (KELIM) is a pragmatic indicator of tumor primary chemosensitivity. Although it is well established that BRCA...
Uploaded on: January 13, 2025 -
August 2022 (v1)Journal article
Background: In spite of the frequency and clinical impact of BRCA1/2 alterations in high-grade epithelial ovarian cancer (HGEOC), real-world information based on robust data warehouse has been scarce to date. Methods: Consecutive patients with BRCA-mutated HGEOC treated between 2011 and 2016 within French comprehensive cancer centers from the...
Uploaded on: November 25, 2023 -
February 2022 (v1)Journal article
Objective: To determine the value of performing a risk-reducting mastectomy (RRM) in the absence of a deleterious variant of a breast cancer susceptibility gene, in 4 clinical situations at risk of breast cancer.Design: The CNGOF Commission of Senology, composed of 26 experts, developed these recommendations. A policy of declaration and...
Uploaded on: November 25, 2023